CN103520542B - Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery - Google Patents
Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery Download PDFInfo
- Publication number
- CN103520542B CN103520542B CN201310486487.4A CN201310486487A CN103520542B CN 103520542 B CN103520542 B CN 103520542B CN 201310486487 A CN201310486487 A CN 201310486487A CN 103520542 B CN103520542 B CN 103520542B
- Authority
- CN
- China
- Prior art keywords
- parts
- intestinal obstruction
- aspongopus
- gecko
- cherchevski
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery. The problem of the treatment of neurogenic intestinal obstruction after abdominal surgery is solved. The composition is characterized by being prepared from the following raw materials in parts by weight: aspongopus, alyxia sinensis, timonius, jasminum grandiflorum, small-flowered wikstroemia, allium victorialis, gastrodia elata Bl., ternate buttercup root, Chinese starjasmine stem, gecko, cassia twig and parched rice-grain sprout. The clinical experiment proves that the composition for treating neurogenic intestinal obstruction after abdominal surgery has the characteristics of good curative effect and high security, and is worthy of clinical application and promotion.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of pharmaceutical composition for the treatment of neurogenic intestinal obstruction after gastrointestinal surgery.
Background technology
Cherchevski's (Neurosis Intestinal Obstruction) is divided into paralytic Cherchevski's and spastic Cherchevski's according to symptom, its pathogenic factor is that abdominal cavity stimulates more, paralytic ileus is more common in acute diffuse peritonitis, retroperitoneal hamorrhage or after infecting because intestinal wall muscular movement is suppressed and lose wriggling ability, intestinal lumen contents can not run downwards; And spastic normal owing to having wound or inflammation inside and outside enteric cavity, foreign bodies etc. stimulate and cause intestinal wall muscle and split contraction by force.Gastrointestinal procedures is then common abdominal cavity stimulating factor.
Cherchevski's is different from common mechanical intestinal obstruction, and the former only has ileac sings and symptoms, but mechanical blocks evidence.
Due to the many paralysis of Cherchevski's performance and spasm alternately outbreak, so there is no effective treatment means clinically now, only there is the postoperative generation that can reduce intestinal adhesion at intraperitoneal placement carboxymethyl cellulose (Sodium carboxymethyl cellulose) and oral vitamin E of report.
The traditional Chinese medical science is many to be recorded without primary disease, and treatment is many to be controlled from symptom opinion, but due to the alternately outbreak of Cherchevski's paralysis and spasm, symptom is unstable, thus treat very passive.
Summary of the invention
Technical assignment of the present invention is for above the deficiencies in the prior art, provides a kind of curative effect certainly and the pharmaceutical composition of the little treatment neurogenic intestinal obstruction after gastrointestinal surgery of side effect.
The technical scheme that the present invention solves its technical problem is: a kind of pharmaceutical composition for the treatment of neurogenic intestinal obstruction after gastrointestinal surgery, it is characterized in that being prepared from by the crude drug of following weight proportion: Aspongopus 10 ~ 30 parts, Herba Alyxiae Sinensis 6 ~ 12 parts, alizarin 3 ~ 10 parts of sea, Flos jasmini 6 ~ 12 parts, Cortex Seu Radix Wikstroemiae Micranthae 3 ~ 10 parts, Bulbus Allii Victorialis 6 ~ 12 parts, go back 6 ~ 12 parts, bobbin, Radix Ranunculi Ternati 6 ~ 12 parts, Caulis Trachelospermi 6 ~ 12 parts, Gecko 1 ~ 5 part, Ramulus Cinnamomi 3 ~ 10 parts, Fructus Setariae Germinatus (parched to brown) 10 ~ 25 parts.
Chinese medicine of the present invention is prepared from by the raw material of following optimum weight part proportioning: Aspongopus 20 parts, Herba Alyxiae Sinensis 10 parts, alizarin 6 parts of sea, Flos jasmini 10 parts, Cortex Seu Radix Wikstroemiae Micranthae 6 parts, Bulbus Allii Victorialis 10 parts, go back 10 parts, bobbin, Radix Ranunculi Ternati 10 parts, Caulis Trachelospermi 10 parts, Gecko 2 parts, Ramulus Cinnamomi 6 parts, Fructus Setariae Germinatus (parched to brown) 20 parts.
Wherein said: Aspongopus is the dry body of Pentatomidae Insects Aspongopus Aspongopus chinensis Dallas.Nature and flavor are salty, temperature.Return liver,spleen,kidney warp.Merit can regulating QI to relieve pain, and warming middle-JIAO is supporing yang.
Herba Alyxiae Sinensis is herb and the root of apocynaceae plant chain pearl rattan.Toil, flat.Enter lung, liver, spleen three warp.Merit can expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral.
Hai Qian is Sargassaceae plant Alga Sgrgassi Enerves Sargassum enerve C.Ag., Sargassum henslowianum Sargassum henslowianum C.Ag., sargassum thunbergii Sargassum thunbergii(Mert.) O.Kuntze or Sargassum phyllocystum Tseng et Lu,Sargassum horneri (Turn.) C. Ag. (Fucus horneri (Turn.)C.Ag.,Spongocarpus horneri Kutz.) argassum horneri(Turn.) frond of C. Ag.Nature and flavor are salty; Cold.Return liver; Stomach; Kidney channel.Merit can hard masses softening and resolving; Removing heat-phlegm.
Flos jasmini is Oleaceae plants Flos jasmini Jasminu, the dry flower of grandiflorum L..Property mildly bitter flavor; Property is put down.Return Liver Channel.Merit can soothing liver-QI for relieving depression, promoting the circulation of QI to relieve pain.
Cortex Seu Radix Wikstroemiae Micranthae is peel of stem and the root of Isolated From Thymelaeaceae Species little Huang structure Wikstroemia micrantha Hemsl..Sweet in the mouth; Property is put down.Return lung meridian.Merit can relieving cough and resolving phlegm; Heat reliving and toxin-eliminating.
Bulbus Allii Victorialis is the bulb of liliaceous plant Bulbus Allii Victorialis Allium victorialis L..Return lung meridian.Merit can dissipating blood stasis; Hemostasis; Removing toxic substances.
Also bobbin is the fruit of orchid Rhizoma Gastrodiae Gastrodia elata Bl..Sweet in the mouth; Cold in nature.Merit can tonify deficiency subduing the wind syndrome.
Radix Ranunculi Ternati is the dried root of ranunculaceae plant Seynuns Kugelann Ranunculus ternatus Thunb..Nature and flavor sweet, acrid, warm.Return liver, lung meridian.Merit can eliminating stagnation, detumescence.
Caulis Trachelospermi is the dry zone leaf rattan of apocynaceae plant trachelospermum jasminoide Trachelospermum jasminoides (Lindl.) Lem..Hardship, is slightly cold.Return kidney, liver, kidney channel.Merit can dispelling wind and removing obstruction in the collateral, and removing heat from blood is subsided a swelling.
Gecko is the dry body of Gekkonidae animal Gecko Gekko gecko Linnaeus.Nature and flavor are salty, flat.Return lung, kidney channel.Merit can invigorating the lung and the kidney, improving inspiration by invigorating kidney-QI Dingchuan, supporing yang benefit essence.
Ramulus Cinnamomi is the withe of canella Cortex Cinnamomi Cinnamomum cassia Presl.Nature and flavor acrid, sweet, warm.Enter the heart, lung, urinary bladder channel.Merit can relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, activating YANG and prormoting functioning of QI.
Fructus Setariae Germinatus (parched to brown), for the mature fruit of grass foxtail millet Setaria italica (L.) Beauv. is through drying of germinateing, fries to burnt brown according to frying method.Nature and flavor are sweet, temperature.Return spleen, stomach warp.Merit can help digestion and in, spleen benefiting and stimulating the appetite.
Compared with prior art, the present invention has following characteristics.
1, set forth one's views unique: start with from dredging collateral, to recover for the purpose of intestinal wall CO2 laser weld, avoid using purgatives medicine thing, although because purgatives medicine thing can solve abdominal distention for the moment, cause again new stimulation to intestinal wall, for a long time raw he become, protracted course of disease.
2, with Aspongopus, Herba Alyxiae Sinensis for monarch: inventor's clinical experience gained, Cherchevski's is a kind of reflexive performance after art midgut wall nerve is upset, and Aspongopus regulating QI to relieve pain, Herba Alyxiae Sinensis promoting blood circulation to remove obstruction in the collateral, can reduce this zest and reflect the untoward reaction brought to intestinal.Basic pharmacology test confirms: Partial small bowel obstruction rat model Aspongopus (20g crude drug/kg/d) and Herba Alyxiae Sinensis (10g crude drug/kg/d) mixing water decocting liquid gavage, can intestinal mucosa injury be reduced, to incomplete intestinal obstruction Intestinal Mucosa, there is protective effect; And the progradation of rat intestine wriggling is observed by charcoal end method, propelling rate (84.42 ± 13.24) % of Aspongopus, Herba Alyxiae Sinensis drug combination group is apparently higher than blank group of (59.33 ± 15.62) %.
3, using sea, alizarin hard masses softening and resolving, Cortex Seu Radix Wikstroemiae Micranthae digestion visible phlegm, Caulis Trachelospermi dispelling wind dredging collateral, Flos jasmini promoting the circulation of QI to relieve pain, Bulbus Allii Victorialis dissipating blood stasis, Radix Ranunculi Ternati mass dissipating and swelling eliminating assist monarch drug as ministerial drug: breath does not reach, of a specified duration then can block by accumulation of phlegm, so select Cortex Seu Radix Wikstroemiae Micranthae, the alizarin visible phlegm removed in intestinal venation in sea, the ability of Flos jasmini, Caulis Trachelospermi, Radix Ranunculi Ternati increase medicine walking venation.Bulbus Allii Victorialis has the advantages that dissipating blood stasis does not consume gas, and after being particularly suitable for gastrointestinal procedures, simulataneous insufficiency and excessive uses.
4, with Gecko invigorating the lung and the kidney, go back the righting of bobbin tonify deficiency subduing the wind syndrome, wherein the aminoacid that contains of Gecko and phospholipid composition can reduce the content of malonaldehyde in cell membrane (MDA), play the effect of stable intestinal cell cell membrane.
5, low dose of Ramulus Cinnamomi is corrigent, resist the anxiety that this prescription invasion by pathogenic cold medicine of a cold nature thing too much has consumption impairment of QI the moon, and the effect of its activating YANG and prormoting functioning of QI is also echoed with Aspongopus, contributes to row loose.
6, Fructus Setariae Germinatus (parched to brown) is sweet in flavor and warm in property, returns taste warp, get protect sun defend in meaning, and contained coking composition has astriction, has the meaning of receipts in loose.
7, the homogeneous medicine multiple-effect of institute's thing of getting it filled in side, contributes to reducing medicament categories and consumption, does not increase Liver and kidney burden.
8, medicine material consumption of the present invention is groped to sum up to draw through inventor in a large number, and each raw material dosage is for all to have good curative effect in following weight parts scope.
Detailed description of the invention
Below in conjunction with practical situation, the specific embodiment of the present invention is elaborated.
Embodiment 1, crude drug weight proportion: Aspongopus 20 parts, Herba Alyxiae Sinensis 10 parts, alizarin 6 parts of sea, Flos jasmini 10 parts, Cortex Seu Radix Wikstroemiae Micranthae 6 parts, Bulbus Allii Victorialis 10 parts, go back 10 parts, bobbin, Radix Ranunculi Ternati 10 parts, Caulis Trachelospermi 10 parts, Gecko 2 parts, Ramulus Cinnamomi 6 parts, Fructus Setariae Germinatus (parched to brown) 20 parts.
The preparation method of embodiment 1 is: by Aspongopus, Herba Alyxiae Sinensis, Hai Qian, Flos jasmini, Cortex Seu Radix Wikstroemiae Micranthae, Bulbus Allii Victorialis, go back bobbin, Radix Ranunculi Ternati, Caulis Trachelospermi, Gecko, Ramulus Cinnamomi, the decoction of Fructus Setariae Germinatus (parched to brown) mixing and water adding, filtrate is got after 30 minutes, medicinal residues add water continue decoction get filtrate after 20 minutes, twice filtrate merges, and is divided into two parts of morning and evenings to take.
Embodiment 2, crude drug weight proportion: Aspongopus 10 parts, Herba Alyxiae Sinensis 6 parts, alizarin 3 parts of sea, Flos jasmini 6 parts, Cortex Seu Radix Wikstroemiae Micranthae 3 parts, Bulbus Allii Victorialis 6 parts, go back 6 parts, bobbin, Radix Ranunculi Ternati 6 parts, Caulis Trachelospermi 6 parts, Gecko 1 part, Ramulus Cinnamomi 3 parts, Fructus Setariae Germinatus (parched to brown) 10 parts.
Embodiment 3, crude drug weight proportion: Aspongopus 20 parts, Herba Alyxiae Sinensis 10 parts, alizarin 6 parts of sea, Flos jasmini 10 parts, Cortex Seu Radix Wikstroemiae Micranthae 6 parts, Bulbus Allii Victorialis 10 parts, go back 10 parts, bobbin, Radix Ranunculi Ternati 10 parts, Caulis Trachelospermi 10 parts, Gecko 2 parts, Ramulus Cinnamomi 6 parts, Fructus Setariae Germinatus (parched to brown) 20 parts.
Embodiment 4, crude drug weight proportion: Aspongopus 30 parts, Herba Alyxiae Sinensis 12 parts, alizarin 10 parts of sea, Flos jasmini 12 parts, Cortex Seu Radix Wikstroemiae Micranthae 10 parts, Bulbus Allii Victorialis 12 parts, go back 12 parts, bobbin, Radix Ranunculi Ternati 12 parts, Caulis Trachelospermi 12 parts, Gecko 5 parts, Ramulus Cinnamomi 10 parts, Fructus Setariae Germinatus (parched to brown) 25 parts.
The Chinese medicine of embodiment 2 ~ 4 can be prepared from by following method:
(1) bobbin will be gone back, Herba Alyxiae Sinensis, Cortex Seu Radix Wikstroemiae Micranthae coarse powder soak separately after 4 hours and extract volatile oil 6 hours with vapor distillation, and mixing for standby use after collecting, medicinal residues are for subsequent use;
(2) Gecko, Fructus Setariae Germinatus (parched to brown) are pulverized 150 mesh sieves, and become fine powder for subsequent use;
(3) by gained medicinal residues mixing in Aspongopus, Hai Qian, Flos jasmini, Bulbus Allii Victorialis, Radix Ranunculi Ternati, Caulis Trachelospermi, Ramulus Cinnamomi and step 1 with 5 times amount 80% ethanol extraction 2 times, each 2 hours, merge twice ethanol extract, filter, reclaiming relative density when ethanol concentrating under reduced pressure become 60 DEG C is the extractum of 1.25 ~ 1.30;
(4) gained fine powder in step 2 is added gained extractum mixing in step 3,60 DEG C of oven dry, are ground into fine powder, add Tween-80 and make granule, and dry, granulate, sprays into gained volatile oil in step 1, and mixing, incapsulates, to obtain final product.
Can set every capsules is 0.5g.
The efficient combination of said medicine, coordinates mutually, effectively reach the object for the treatment of neurogenic intestinal obstruction after gastrointestinal surgery, and side effect is less.The above results is clinical data sufficient proof, and interrelated data is as follows.
1 object and method.
1.1 object.
1.1.1 case selection: case is selected from case 70 example that in June, 2010 ~ 2013 are diagnosed as Cherchevski's year June.All cases are abdominal surgery gastrointestinal procedures postoperative patient.
1.1.2 Cherchevski's diagnostic criteria: (1) suffers from abdominal pain: paroxysmal abdominal pain; (2) vomit: high obstruction vomiting is comparatively frequent, it is less that low level blocks vomiting number of times, and vomitus is smelly with excrement; (3) abdominal distention: low level blocks full abdominal distention, often accompanies visible peristalsis visible intestinal peristalsis, high obstruction abdominal distention is not obvious; (4) aerofluxus and defecation stop; (5) sign: the intestinal tube of expansion has tenderness, rebound tenderness; Borborygmus is faint or disappear or gur gling; (6) x-ray diagnosis intestinal blocks important value.And get rid of mechanical intestinal obstruction.
1.1.3 three groups are divided at random: matched group 25 example, decoction group 23 example, Capsules group 22 example.Compare in sex, age, art formula before three groups of patient treatments, no significant difference (P>0.05), has comparability.
1.2 method.
1.2.1 Therapeutic Method: matched group takes gastrointestinal decompression, fluid infusion, correction acid base imbalance, anti-infective therapy, decoction group adds with embodiment 1 gained decoction on matched group medication basis, 2 times/d; Capsules group adds described embodiment 3 gained capsule 2g/ time on matched group medication basis, 2 times/d, altogether 5d.
1.2.2 judge according to criterion of therapeutical effect ileac in " new Chinese medicine guideline of clinical investigations ".Recovery from illness: Clinical symptom and sign disappears, normal passage of gas by anus defecation, borborygmus recovers, and X-ray of abdomen intestinal tube inflatable dilatation disappears, and can pull out gastrointestinal decompression tube.Effective: Clinical symptom and sign obviously alleviates, borborygmus recovers substantially, and X-ray of abdomen intestinal tube inflatable dilatation obviously alleviates, and can close gastrointestinal decompression tube and observe.Effective: abdominal part distending pain alleviates to some extent, aerofluxus, defecation are not smooth, and abdominal part auscultation borborygmus is weak, and X-ray of abdomen intestinal tube inflatable dilatation alleviates, and still needs indwelling gastrointestinal decompression tube.Invalid: still without aerofluxus, defecation after medication 72 h, Clinical symptom and sign is without alleviation or increase the weight of.
1.2.3 statistical analysis: SPSS 13.0 carries out statistical analysis.Measurement data t checks, enumeration data χ
2inspection.
2 results.
2.1 3 groups of Clinical efficacy comparisons: see the following form.Result shows: the cure rate of decoction group and Capsules group is apparently higher than matched group (decoction group P<0.01; Capsules group P<0.05); Total effective rate is apparently higher than matched group (P<0.05).
| Group | Number of cases | Recovery from illness | Effective | Effectively | Invalid | Total effective rate |
| Matched group | 25 | 2（8.00%） | 9（36.00%） | 7（28.00%） | 7（28.00%） | 72.00% |
| Decoction group | 23 | 12（52.17%） | 7（30.43%） | 3（13.04%） | 1（4.35%） | 95.65% |
| Capsules group | 22 | 5（22.73%） | 11（50.00%） | 4（18.18%） | 2（9.09%） | 90.91% |
Relapse rate in 2.2 3 groups of patient half days: the effective patient for the treatment of of control group had 22.22%(4/18 in three months) patient there is recurrence, decoction group is 4.55%(1/22), Capsules group is 5.00%(1/20), the relapse rate of decoction group and Capsules group is starkly lower than matched group (P<0.01).
2.3 3 groups of adverse reactions of patients incidence rates compare: three groups all do not occur obvious adverse reaction record.
3. conclusion.
This result of study shows, after taking decoction of the present invention or capsule, neurogenic intestinal obstruction after gastrointestinal surgery patient cure rate, total effective rate are apparently higher than matched group, and relapse rate is starkly lower than matched group, there is not obvious adverse reaction record, illustrate that pharmaceutical composition of the present invention has the lighter advantage of good effect, untoward reaction in treatment neurogenic intestinal obstruction after gastrointestinal surgery.
Claims (2)
1. treat a pharmaceutical composition for abdominal postoperative Cherchevski's, it is characterized in that being prepared from by the crude drug of following weight proportion: Aspongopus 10 ~ 30 parts, Herba Alyxiae Sinensis 6 ~ 12 parts, alizarin 3 ~ 10 parts of sea, Flos jasmini 6 ~ 12 parts, Cortex Seu Radix Wikstroemiae Micranthae 3 ~ 10 parts, Bulbus Allii Victorialis 6 ~ 12 parts, go back 6 ~ 12 parts, bobbin, Radix Ranunculi Ternati 6 ~ 12 parts, Caulis Trachelospermi 6 ~ 12 parts, Gecko 1 ~ 5 part, Ramulus Cinnamomi 3 ~ 10 parts, Fructus Setariae Germinatus (parched to brown) 10 ~ 25 parts; Described pharmaceutical composition is used for the treatment of abdominal postoperative Cherchevski's.
2. a kind of pharmaceutical composition for the treatment of abdominal postoperative Cherchevski's according to claim 1, is characterized in that being prepared from by the crude drug of following weight proportion: Aspongopus 20 parts, Herba Alyxiae Sinensis 10 parts, alizarin 6 parts of sea, Flos jasmini 10 parts, Cortex Seu Radix Wikstroemiae Micranthae 6 parts, Bulbus Allii Victorialis 10 parts, go back 10 parts, bobbin, Radix Ranunculi Ternati 10 parts, Caulis Trachelospermi 10 parts, Gecko 2 parts, Ramulus Cinnamomi 6 parts, Fructus Setariae Germinatus (parched to brown) 20 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310486487.4A CN103520542B (en) | 2013-10-17 | 2013-10-17 | Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310486487.4A CN103520542B (en) | 2013-10-17 | 2013-10-17 | Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520542A CN103520542A (en) | 2014-01-22 |
| CN103520542B true CN103520542B (en) | 2015-06-03 |
Family
ID=49923129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310486487.4A Expired - Fee Related CN103520542B (en) | 2013-10-17 | 2013-10-17 | Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520542B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105797137B (en) * | 2016-06-02 | 2020-06-19 | 张希芳 | Compound nursing preparation for treating neurosis intestinal obstruction after abdominal operation and preparation method thereof |
| CN106310224A (en) * | 2016-08-31 | 2017-01-11 | 王蕾 | Compound nursing preparation for treating nervous intestinal obstruction after abdominal operation and preparation method of compound nursing preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101857A (en) * | 1993-10-22 | 1995-04-26 | 杜军强 | Chinese-medicinal imaging assistant to stomach for ultrasonography B and preparing process |
| CN1429603A (en) * | 2002-12-02 | 2003-07-16 | 张方平 | Medicine for treating stomach disease |
-
2013
- 2013-10-17 CN CN201310486487.4A patent/CN103520542B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101857A (en) * | 1993-10-22 | 1995-04-26 | 杜军强 | Chinese-medicinal imaging assistant to stomach for ultrasonography B and preparing process |
| CN1429603A (en) * | 2002-12-02 | 2003-07-16 | 张方平 | Medicine for treating stomach disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520542A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520542B (en) | Medicinal composition for treating neurogenic intestinal obstruction after gastrointestinal surgery | |
| CN103495071B (en) | Capsule for treating neurosis intestinal obstruction after gastrointestinal surgery and preparation method thereof | |
| CN101695527B (en) | Toxin-expelling intestine-moistening Chinese medicinal preparation and preparation method thereof | |
| CN104042713B (en) | A kind of Chinese medicine composition for the treatment of bronchial asthma | |
| CN103495070B (en) | Navel-applied agent for treating bowel dysfunction after abdominal surgery | |
| CN103495069B (en) | Pharmaceutical composition for treating postpartum neurosis intestinal obstruction | |
| CN113616758A (en) | Traditional Chinese medicine suitable technology for treating functional constipation of children by external application of medicine | |
| CN103520613B (en) | One treats anesthetis bowel syndrome capsule and preparation method thereof | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN103520541B (en) | Dressing umbilicus granule for treating postnatal neurosis intestinal obstruction and preparation method thereof | |
| CN103520614B (en) | A kind of pharmaceutical composition for the treatment of anesthetis bowel syndrome | |
| CN108771658A (en) | A kind of bowel relaxing oral liquid and preparation method | |
| CN104491560B (en) | A kind of oral drugs for treating postpartum Cherchevski's | |
| CN103191339B (en) | Method for preparing drug for treating pediatric esophageal achalasia | |
| CN103505657B (en) | Belly patch for treating intestinal dysfunction after abdominal cavity surgery and preparation method of belly patch | |
| CN107737292B (en) | Traditional Chinese medicine preparation for treating senile nocturia and preparation method thereof | |
| CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
| CN105079094A (en) | Traditional Chinese medicine composition for treating hemafecia | |
| CN103191338B (en) | Pharmaceutical composition for treating pediatric esophageal achalasia | |
| CN103191335B (en) | Pharmaceutical composition for treating esophageal achalasia | |
| CN103191336B (en) | Method for preparing drug for treating esophageal achalasia | |
| CN103977126A (en) | Fever reducing sugared pills for treating fever in children and preparation method thereof | |
| CN103301314B (en) | Medicament for organ detoxification and preparation method thereof | |
| CN112022953A (en) | Traditional Chinese medicine composition for clearing intestines and stomach and expelling toxin and preparation method thereof | |
| CN110604765A (en) | Traditional Chinese medicine composition for treating diarrhea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150603 Termination date: 20151017 |
|
| EXPY | Termination of patent right or utility model |